61 results
PRE 14A
SHPH
Shuttle Pharmaceuticals Holdings Inc
10 Jun 24
Preliminary proxy
6:12am
). In making this determination, our Board of Directors considered the relationships that each of these non-employee directors has with us and all other … be a non-employee director who has been determined by the Board of Directors to meet the independence requirements under Nasdaq rules, and also Rule 10A-3(b
424B3
SHPH
Shuttle Pharmaceuticals Holdings Inc
22 Mar 24
Prospectus supplement
6:07am
inventions conceived by an employee will be the property of our company. There can be no assurance, however, that these agreements will provide meaningful … and infrastructure may be vulnerable to attacks by hackers or breached due to employee error, malfeasance or other disruptions. Although to our
8-K
EX-10.1
SHPH
Shuttle Pharmaceuticals Holdings Inc
5 Feb 24
Entry into a Material Definitive Agreement
4:25pm
to Shuttle Pharma by Purchaser’s employee and co-inventor.
7.4 Restrictions on Rights. Purchaser will not be subject to any covenant not to sue
8-K
EX-10.1
grb3xd55h5lcwqnpiyuk
30 Oct 23
Shuttle Pharma Advances Prostate Cancer Predictive Biomarker Program Through Exclusive License Agreement
5:14pm
8-K
EX-10.1
5cee7fzidlrer7ezl70
5 Oct 23
Entry into a Material Definitive Agreement
4:10pm
424B3
ljsojqx01w8q7rvlr7h
24 Aug 23
Prospectus supplement
2:00pm
S-8
o26w434
12 Dec 22
Registration of securities for employees
4:23pm
DEF 14A
xqai2q
21 Nov 22
Definitive proxy
5:28pm
8-K
EX-10.1
5nz4qs bic1g0t8nf
1 Nov 22
Shuttle Pharmaceuticals Appoints Bette Jacobs to its Board of Directors
9:00am
8-K
EX-3.1
da4ty3gdgjjm
1 Nov 22
Shuttle Pharmaceuticals Appoints Bette Jacobs to its Board of Directors
9:00am
DRS
x30 1cfe76jadaz75xc5
29 Sep 22
Draft registration statement
12:00am
424B4
samv6853
31 Aug 22
Prospectus supplement with pricing info
6:16am